Logo image of ASTH

ASTRANA HEALTH INC (ASTH) Stock Analyst Earnings Estimates

NASDAQ:ASTH - Nasdaq - US03763A2078 - Common Stock - Currency: USD

25.38  -9.3 (-26.82%)

After market: 26.25 +0.87 (+3.43%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
ASTH revenue by date.ASTH revenue by date.
773.915M
12.62%
1.144B
47.84%
1.387B
21.19%
2.026B
46.11%
2.72B
34.25%
3.379B
24.23%
3.384B
0.15%
3.782B
11.76%
4.218B
11.53%
4.696B
11.33%
5.221B
11.18%
EBITDA
YoY % growth
ASTH ebitda by date.ASTH ebitda by date.
115.696M
17.04%
121.808M
5.28%
102.361M
-15.97%
173.39M
69.39%
215.13M
24.07%
267.06M
24.14%
290.7M
8.85%
338.64M
16.49%
395.76M
16.87%
459M
15.98%
531.42M
15.78%
EBIT
YoY % growth
ASTH ebit by date.ASTH ebit by date.
98.179M
21.96%
104.265M
6.20%
84.613M
-18.85%
103.69M
22.55%
125.76M
21.28%
171.3M
36.21%
211.45M
23.44%
255.41M
20.79%
306M
19.81%
362.1M
18.33%
425.44M
17.49%
Operating Margin
ASTH operating margin by date.ASTH operating margin by date.
12.69%9.11%6.10%5.12%4.62%5.07%6.25%6.75%7.25%7.71%8.15%
EPS
YoY % growth
ASTH eps by date.ASTH eps by date.
1.57
270.65%
1.06
-32.48%
1.32
24.53%
1.18
-32.58%
1.45
62.55%
1.94
34.05%
2.59
33.60%
3.05
17.72%
3.55
16.39%
4.03
13.51%
4.55
12.91%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.35
11.87%
0.38
-5.65%
0.37
11.27%
0.31
309.66%
0.33
-5.88%
0.37
-2.70%
0.40
8.33%
0.34
7.03%
Revenue
Q2Q % growth
624.53M
54.45%
637.27M
31.05%
725.77M
51.61%
780.15M
17.28%
851.4M
36.33%
874.31M
37.20%
864M
19.05%
901.14M
15.51%
EBITDA
Q2Q % growth
49.345M
40.05%
52.065M
22.21%
58.547M
21.40%
56.793M
65.12%
67.624M
37.04%
72.797M
39.82%
74.035M
26.45%
72.284M
27.28%
EBIT
Q2Q % growth
31.417M
4.24%
35.269M
17.31%
35.608M
25.27%
28.979M
117.79%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
-0.15
-157.69%
0.12-0.27-225.16%
Q3 2024
Q2Q % growth
0.33
-29.79%
0.320.011.74%
Q2 2024
Q2Q % growth
0.40
42.86%
0.400.000.55%
Q1 2024
Q2Q % growth
0.31 0.310.000.75%
Q4 2023
Q2Q % growth
0.26
533.33%
0.150.1171.85%
Q3 2023
Q2Q % growth
0.47
-16.07%
0.340.1339.63%
Q2 2023
Q2Q % growth
0.28
12.00%
0.260.039.80%
Q1 2023
Q2Q % growth
0.31 0.310.00-0.90%
Q4 2022
Q2Q % growth
-0.06
-120.00%
-0.090.0334.64%
Q3 2022
Q2Q % growth
0.56
-18.84%
0.320.2472.38%
Q2 2022
Q2Q % growth
0.25
-10.71%
0.210.0420.74%
Q1 2022
Q2Q % growth
0.31
3.33%
0.33-0.02-5.02%
Q4 2021
Q2Q % growth
0.30
11.11%
0.270.0310.99%
Q3 2021
Q2Q % growth
0.69
53.33%
0.350.3498.96%
Q2 2021
Q2Q % growth
0.28
116.00%
0.210.0730.72%
Q1 2021
Q2Q % growth
0.30
172.73%
0.220.0833.69%
Q4 2020
Q2Q % growth
0.27
50.00%
0.180.0947.06%
Q3 2020
Q2Q % growth
0.45
350.00%
0.220.23100.53%
Q2 2020
Q2Q % growth
-1.75
-2,044.44%
0.07-1.82-2,550.98%
Q1 2020
Q2Q % growth
0.11 0.040.07169.61%
Q4 2019
Q2Q % growth
0.18 0.20-0.02-11.76%
Q3 2019
Q2Q % growth
0.10 0.14-0.04-29.97%
Q2 2019
Q2Q % growth
0.09 0.050.0476.47%
Q1 2019
Q2Q % growth
0.00 0.08-0.08-100.00%
ASTH Yearly EPS VS EstimatesASTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
665.21M
88.43%
629.59M35.62M5.66%
Q3 2024
Q2Q % growth
478.71M
37.49%
471.62M7.09M1.50%
Q2 2024
Q2Q % growth
486.265M
39.65%
449.57M36.695M8.16%
Q1 2024
Q2Q % growth
404.356M
19.90%
422.13M-17.774M-4.21%
Q4 2023
Q2Q % growth
353.036M
40.79%
347.99M5.046M1.45%
Q3 2023
Q2Q % growth
348.173M
26.61%
357.1M-8.927M-2.50%
Q2 2023
Q2Q % growth
348.209M 348.81M-601K-0.17%
Q1 2023
Q2Q % growth
337.244M 324.43M12.814M3.95%
Q4 2022
Q2Q % growth

41.09%
250.76M%
Q3 2022
Q2Q % growth

51.46%
274.99M%
Q4 2021
Q2Q % growth

5.92%
177.73M%
Q3 2021
Q2Q % growth

6.39%
181.56M%
Q2 2021
Q2Q % growth

4.65%
174.32M%
Q1 2021
Q2Q % growth

3.33%
175.17M%
Q4 2020
Q2Q % growth

7.03%
167.79M%
Q3 2020
Q2Q % growth

1.20%
170.65M%
Q2 2020
Q2Q % growth

22.83%
166.57M%
Q1 2020
Q2Q % growth

26.39%
169.52M%
ASTH Yearly Revenue VS EstimatesASTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-15.52% -15.47% -0.41% -8.45%
Revenue2.75% 3.18% 0% 5.91%